Price loading...

Peritoneal Carcinomatosis from Ovarian Cancer

Price data last checked 101 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Ovarian cancer is the most common cause of death among all gynecological neoplasms. Ovarian epithelial cancer represents approximately 90% of all ovarian malignant tumours. The most usual pattern of spread and probably the earliest kind of metastasis of ovarian cancer is intraperitoneal spread, caused by apoptosis of viable cancer cells, even in cases where the ovarian surface has no visible rupture. Approximately 70% to 75% of all ovarian cancers are being diagnosed with peritoneal carcinomatosis and ascites in advanced stages III and IV. Peritoneal carcinomatosis from ovarian cancer may occur either concomitantly with the primary tumour or as a recurrence pattern of spread. Standard treatment consists of surgical debulking and postoperative systemic chemotherapy. Response rates to first-line chemotherapy with platinum/taxane combinations are high, about 70-80%, but the vast majority of patients will relapse. Peritoneal seeding is a major cause of surgical treatment failure among those patients, even after optimal debulking. However, progressing ovarian cancer tends to remain within the peritoneal cavity or, better-expressed, ovarian cancer is a cancer of the peritoneum. The administration of cytotoxic agents directly into the peritoneal cavity as treatment for malignancy was initially evaluated more than 40 years ago. Over the past two decades regional therapy of ovarian cancer has evolved from just an interesting pharmacokinetic concept into a viable management option for women with advanced disease. Several authors, and among them some of the world's leading experts on this field present the current knowledge and their experience on peritoneal carcinomatosis from ovarian cancer.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
08 April 2005
Listed Since
05 February 2007

Barcode

No barcode data available

Similar Products You Might Like

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
94% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£135.35 08 Mar 2026
Intraperitoneal Therapy for Ovarian Cancer
94% match

Intraperitoneal Therapy for Ovarian Cancer

Springer

£106.59 15 Jan 2026
Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)
94% match

Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)

Springer

£149.20 10 Mar 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
94% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£92.56 06 Mar 2026
Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)
94% match

Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)

Springer

£80.09 09 Mar 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
94% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£242.71 23 Jan 2026
Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)
94% match

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Springer

£201.01 23 Jan 2026
Endometrial Cancer: Clinical and Translational Update Book
93% match

Endometrial Cancer: Clinical and Translational Update Book

£135.73 18 Apr 2026
Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy
93% match

Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy

Springer

£113.97 09 Mar 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
93% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£79.93 06 Mar 2026
Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)
93% match

Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)

Humana

£85.07 13 Apr 2026
Pathology of Peritoneal Metastases: The Unchartered Fields
93% match

Pathology of Peritoneal Metastases: The Unchartered Fields

Springer

£88.34 05 Feb 2026
Fere Ex Nihilo - Ovarian Oncogenesis Recapitulates Phylogenesis: A Hormonal Approach To Ovarian Cancer Mirroring The Development Of The Mullerian Tract
93% match

Fere Ex Nihilo - Ovarian Oncogenesis Recapitulates Phylogenesis: A Hormonal Approach To Ovarian Cancer Mirroring The Development Of The Mullerian Tract

World Scientific Publishing Company

£84.99 19 Feb 2026
Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6
93% match

Methods of Cancer Diagnosis, Therapy, and Prognosis: Ovarian Cancer, Renal Cancer, Urogenitary tract Cancer, Urinary Bladder Cancer, Cervical Uterine ... Leukemia, Multiple Myeloma and Sarcoma: 6

Springer

£165.82 14 Jan 2026
Uterine Cancer: Diagnosis and Treatment
93% match

Uterine Cancer: Diagnosis and Treatment

Springer

£93.19 09 Mar 2026
Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)
93% match

Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)

Springer

£103.00 12 Dec 2025
Advances in Diagnosis and Management of Ovarian Cancer
93% match

Advances in Diagnosis and Management of Ovarian Cancer

Springer

£119.99 01 Mar 2026
Intraperitoneal Cancer Therapy (Current Clinical Oncology)
93% match

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Humana

£38.89 09 Jan 2026
Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond
93% match

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Springer

£81.28 25 Jan 2026
Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)
93% match

Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)

Elsevier

£68.52 28 Feb 2026
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
93% match

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

MDPI AG

£64.85 19 Apr 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
93% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£103.30 02 Apr 2026
Springer Ovarian Cancer: Second Edition - Medical Textbook
93% match

Springer Ovarian Cancer: Second Edition - Medical Textbook

Springer

£30.42 07 Mar 2026
Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
93% match

Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

Springer

£87.83 08 Jan 2026